Search results
Julian Assange supporters ‘overjoyed’ by Wikileaks founder’s plea deal and release
The Independent via Yahoo News Singapore· 6 days ago“As he returns to Australia, we thank all who stood by us, fought for us, and remained utterly...
Julian Assange: Timeline of WikiLeaks founder's 13-year legal battle for freedom
Sky News via Yahoo News Singapore· 6 days agoWikiLeaks founder Julian Assange has left prison in the UK after reaching a plea deal with the US...
Julian Assange spent 5 years in a 2x3 meter cell, isolated 23 hours a day before his release on...
INSIDER via Yahoo News Singapore· 5 days agoJudges ruled in 2004 that the indefinite detention of foreign prisoners in Belmarsh without trial...
Here are all the top contenders to be Trump's vice-presidential nominee in 2024
INSIDER via Yahoo News Singapore· 4 days agoFormer White House chief of staff Mick Mulvaney told Sky News Australia in early June that Carson...
Julian Assange’s mission was to change the world - but at what cost?
CNN via Yahoo News Singapore· 5 days agoJulian Assange started his WikiLeaks whistleblowing website on a quest for “radical transparency and...
Ex-Millionaires Are Revealing How They Lost All Their Money, And I'm Actually Speechless
BuzzFeed via Yahoo Singapore Finance· 5 days agoIt boggles my mind." 15."My parents were both smart people. They went to the best universities and...
Hyzon (HYZN) Shifts Focus to North America & Refuse Industry
Zacks via Yahoo Singapore Finance· 5 days agoDuring this exploration, Hyzon will continue to focus on reducing costs and managing liquidity,...
Former Jetstar pilot convicted of murdering elderly woman at Australian campsite
The Independent via Yahoo News Singapore· 6 days agoLynn, a 57-year-old former pilot, had pleaded not...camping together, sparking one of the largest...
Glaukos (GKOS) Reaches 52-Week High: What's Driving the Stock?
Zacks via Yahoo Singapore Finance· 3 days agoDownsides Pipeline Setbacks: Although Glaukos has a promising pipeline, it has faced setbacks with...
AstraZeneca's Imfinzi fails in late-stage trial to treat certain lung cancers
Reuters via Yahoo Singapore Finance· 6 days agoImfinzi is a human monoclonal antibody, which works to block a tumour's ability to evade and dampen...